Affiliation:
1. Infectious Disease Laboratory, Department of Medicine, The Methodist Hospital, Baylor College of Medicine, Houston, Texas 77025
Abstract
Josamycin, a new macrolide antibiotic, was compared with ampicillin, erythromycin, and clindamycin in vitro against 25 isolates each of pneumococci, enterococci,
Staphylococcus aureus, S. epidermidis
, and nonenterococcal hemolytic streptococci and against 25 anaerobes including 10
Bacteroides fragilis
. Minimal inhibitory concentration and minimal bactericidal concentration data were obtained for the aerobic organisms, using serial twofold tube dilutions in Mueller-Hinton broth. Minimal inhibitory concentrations were determined for the anaerobes by the agar dilution technique. Josamycin was comparable to erythromycin and clindamycin in activity against the pneumococci, streptococci, and staphylococci and was more active than clindamycin against enterococci. It was somewhat less active than ampicillin against enterococci and
S. epidermidis
and showed its greatest in vitro activity against anaerobes, being comparable to clindamycin.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference8 articles.
1. Subcommittee on Taxonomy of Staphylococci and;Baird-Parker A. C.;Micrococci. Int. Bull. Bacteriol. Nomencl. Taxon.,1965
2. Pharmacokinetics of josamycin: a new macrolide antibiotic;Bergan T.;Pharmacology,1972
3. Influence of food and hepatobiliary disease on the excretion of josamycin;Bergan T.;Pharmacology,1972
4. Fukushima K. 1969. Clinical study of josamycin p. 750-754. In Progress in antimicrobial and anticancer chemotherapy. Proccedings of the Sixth International Congress of Chemotherapy vol. 1.
5. The antibacterial action of erythromycin;Haight T. H.;Proc. Soc. Exp. Biol. Med.,1952
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献